ICAM2 and neoplasm: Six weeks after mammary fat pad injection in the 100 tumor cells, 25% of mice in the ICAM2-overexpressing group reported tumor formation, whereas no tumor was detected in the vector control group until the tenth week (Fig. 4C and Supplementary Fig. S6D).